Cryo Cell International (CCEL) Invested Capital (2010 - 2026)

Cryo Cell International has disclosed Invested Capital across 17 years of filings, most recently posting -$16.8 million for Q1 2026.

• In Q1 2026, Invested Capital fell 66.57% year-over-year to -$16.8 million; the TTM figure through Feb 2026 stood at -$16.8 million (down 66.57% YoY), while the FY2025 annual figure was -$16.3 million, down 68.17% from the prior year.
• Invested Capital fell to -$16.8 million in Q1 2026, from -$16.3 million in the prior quarter.
• Over the last five years, Invested Capital for CCEL reached as high as $4.4 million in Q2 2022 and fell as low as -$16.8 million in Q1 2026.
• The 5-year median for Invested Capital is -$7.3 million (2024), against an average of -$5.5 million.
• Annual changes were most pronounced in 2022 — Invested Capital soared 350.8% — and 2023, when it plunged 1410.55%.
• A 5-year view of Invested Capital shows it stood at $748426.0 in 2022, then sank by 1410.55% to -$9.8 million in 2023, then rose by 1.15% to -$9.7 million in 2024, then plunged by 68.17% to -$16.3 million in 2025, then dropped by 3.03% to -$16.8 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered -$16.8 million, -$16.3 million, and -$11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.